Drawing backlash from multiple medical organizations, the CDC website has been updated to suggest a vaccine-autism link. In his January confirmation hearing RFK Jr said he would not impose his personal antivax views. ➡️ www.empr.com/news/medical...

Tonmya (cyclobenzaprine HCl sublingual tablets) is now commercially available, the first new FDA-approved fibromyalgia treatment in over 15 years. #Fibromyalgia #DrugApprovals #NewDrug www.empr.com/news/fibromy...

October 2025 Drug Approvals: Our at-a-glance essential prescribing update. ➡️ www.empr.com/news/october...

The FDA has fully approved Komzifti (ziftomenib), the first and only once-daily oral menin inhibitor, for adults with R/R NPM1-mutated AML. www.empr.com/news/komzift...

Get yourself up to date on Lynkuet — a treatment approved for vasomotor symptoms due to menopause — with our InsightRx interview with trial investigator Dr JoAnn Pinkerton. www.empr.com/news/lynkuet...

Law feature: This month's case resulted in a jury finding in favor of the patient to the tune of $40 million dollars and apportioned the pharmacist's fault at 2%. www.empr.com/features/dos...

Lynkuet was recently approved to treat vasomotor symptoms due to menopause, hear all about it in our interview with one of the trial investigators in our latest InsightRx! www.empr.com/news/lynkuet...

Current evidence for the use of leucovorin to treat autism symptoms is mainly limited to small studies and case reports in children with CFD. www.empr.com/news/aap-cur...

From ACR 2025: biologic disease-modifying antirheumatic drugs (DMARDs) appear to be tied to worse COVID-19 outcomes than conventional DMARDs. www.empr.com/reports/biol...

This Class II Neutrogena recall involves 1312 cases of the 50-count, 25-pack towelettes. www.empr.com/news/neutrog...

Prefilled single-dose autoinjector now available for treatment of migraine and cluster headache. www.empr.com/news/brekiya...

🎧 Latest MPR Pod out now! 🔹 Label changes for tranexamic acid; 🔸 New approval for Tezspire; 🔹 Psychedelic gains Breakthrough Tx status for depression; 🔸 Oral semaglutide approved to reduce MACE risk in T2DM; and 🔹 Gazyva approved for lupus nephritis. www.empr.com/news/mpr-wee...

Findings showed the study did not meet its primary endpoint of preventing CMV infection in seronegative participants. www.empr.com/news/moderna...

Tylenol maker urges regulators to not add autism warning to label citing a lack of scientific evidence. www.empr.com/news/fda-and...

Drug combo gets Priority Review for possible adjuvant treatment in patients with muscle-invasive bladder cancer. www.empr.com/news/enfortu...

There have been continued reports of tranexamic acid being erroneously administered resulting in serious harm and prompting this label change. www.empr.com/news/fda-adm...

Participants in a social anxiety treatment trial were tasked with delivering a 5 minutes speech with 2 minutes notice. The results did not match the primary endpoint. www.empr.com/news/negativ...

From 2005 to 2024, an estimated 3,112 pickleball-related ocular injuries occurred, with 1,262 injuries occurring in 2024 alone. www.empr.com/news/pickleb...

A psychedelic nasal spray has been designated a Breakthrough therapy by the FDA. www.empr.com/news/intrana...

Jascayd was recently approved to treat idiopathic pulmonary fibrosis, we spoke to one of the trial investigators it in our latest InsightRx. www.empr.com/news/jascayd...

📢 Latest MPR Podcast out now! 🔹 New treatment approved for bipolar I disorder; 🔸 Rinvoq IBD indications updated; 🔴 Blood-based test for early detection of amyloid pathology; and 💊 Oral GLP-1 treatment continues to show promise in T2D. www.empr.com/news/mpr-wee...

Review period extended for novel Hunter syndrome treatment. www.empr.com/news/fda-ext...

Law Feature: Jury awards enormous sum to patient who suffered devastating consequences from medical procedure. www.empr.com/features/jur...

Rhapsido was recently approved for chronic spontaneous urticaria, find out all about it from one of the clinical trial investigators on MPR's InsightRx. www.empr.com/news/rhapsid...

Immunization schedule changes approved for COVID-19 vaccines. www.empr.com/news/cdc-app...

The FDA said the application could not be approved due to a lack of substantial efficacy from the submitted studies. www.empr.com/news/fda-den...

📢 MPR Pod out now! 🔸 New Tx approved for primary humoral immunodeficiency; 👀 Eyedrops available to improve near vision; 👦 Tremfya expanded to include pediatric patients; 🔹 FDA Fast Tracks treatments for methamphetamine intoxication, Alzheimer disease. www.empr.com/news/mpr-wee...

Potential treatment for autosomal dominant polycystic kidney disease gains Fast Track status. www.empr.com/news/fda-fas...

Oral option approved to treat chronic spontaneous urticaria. www.empr.com/news/rhapsid...

Recently approved eye drop to treat presbyopia now available. www.empr.com/news/vizz-ey...

Tremfya gets OK'd for patients 6 years and older. www.empr.com/news/tremfya...

Qivigy supplies a broad spectrum of opsonizing and neutralizing IgG antibodies against bacterial and viral agents. www.empr.com/news/qivigy-...

🎧 Latest MPR Pod out now and its been a week! 🔹 CDC recs changes to MMRV vax; 🔸 Trump admin make acetaminophen-autism claim; 🔹 Barth syndrome Tx gets green light; 🔸 Breakthrough in Huntington disease; and 🔹 SC formulation of Keytruda. www.empr.com/news/mpr-wee...

Gene therapy demonstrates success in Huntington disease, slowing disease progression by 75%. www.empr.com/news/gene-th...

Intranasal carbetocin misses in Prader-Willi syndrome trial. www.empr.com/news/intrana...

Flanked by his HHS Secretary, NIH Director, and FDA Commissioner, President Trump repeatedly said 'Don't take Tylenol' in a digressive press conference. www.empr.com/news/trump-a...

California, Hawaii, Oregon and Washington recommend COVID-19 shots for young children, older adults and pregnant women. www.empr.com/news/west-co...

New device approved to prevent intrauterine adhesions. www.empr.com/news/fda-cle...

The ACIP voted 8 to 3 recommending children 12 months through 3 years be immunized for varicella separately from MMR, rather than with the combo vaccine, for the first dose. www.empr.com/news/acip-ch...

New study data will be submitted to regulatory authorities to support expanding the indication for Mounjaro (tirzepatide) to include treatment in pediatric T2D. www.empr.com/news/tirzepa...

The Womed Leaf consists of a proprietary polymer that is inserted into the uterine cavity immediately after completion of a hysteroscopic adhesiolysis procedure. www.empr.com/news/fda-cle...

Large studies have shown that COVID-19 vaccines are safe in pregnancy, yet the new vaccine advisory group say they will review safety. www.empr.com/news/us-offi...

For more than 30 years, the first of 3 shots of hepatitis B vaccine has been recommended for infants. In that time, the potentially fatal disease has been virtually eradicated among US children. www.empr.com/news/rfk-jr-...

💊 Need a recap of drugs in the pipeline updates from August? We got you covered: www.empr.com/news/august-...

View all the drug approval decisions expected to take place in October. www.empr.com/news/fda-dru...

Findings from the trial reinforce data supporting the approval of the LP.8.1-adapted COVID-19 vaccine for the upcoming season. www.empr.com/news/pfizer-...

The CDC director is refusing to resign; being confirmed by the Senate means only the president can fire Dr Monarez, a point made by her lawyer. www.empr.com/news/cdc-lea...

"Frankly, I’m looking over my shoulder driving home," a Midwestern doctor said, after surrendering a work cellphone to supervisors after their hospital received a subpoena. www.empr.com/news/us-just...

An investigative pill, designed for once daily use, shows significant weight reduction in obesity vs placebo. www.empr.com/news/orforgl...

Chikungunya vaccine suspended by FDA as Agency say benefit does not outweigh risks. www.empr.com/news/fda-lic...